Rebecca Benham Vautour, PhD, is interested in studying the role of neuronal inhibitory signaling in neuropsychiatric disorders. This interest developed during her thesis research at Boston University where she was awarded a pre-doctoral NRSA to study the role of BDNF signaling in altering brain inhibitory processes. In the Laboratory of Genetic Neuropharmacology at McLean Hospital, Dr. Benham Vautour’s research utilizes pharmacological agents and genetically modified mice to study the role of specific GABA-A receptor subtypes in depression and its treatment.
In addition to her research, Dr. Benham Vautour has mentored a number of students and research assistants in the Laboratory of Genetic Neuropharmacology. Furthermore, she has served as a reviewer for several peer-reviewed journals.